Encompass Health Credit Rating & NNN Cap Rate Analysis

Encompass Health Business Overview & NNN Investment Profile

Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, a position it has held for decades. The company operates 173 hospitals across 39 states and Puerto Rico, treating 263,299 patient discharges in 2025 with 11,465 licensed beds. Revenue reached $5.94 billion in fiscal year 2025, a 10.5% increase over 2024, while adjusted EBITDA grew 14.9%. The company added 517 inpatient rehabilitation beds during 2025 through eight new hospital openings and 127 bed additions to existing facilities, demonstrating the scale and pace of its expansion.

Encompass Health’s business model is built on a critical and growing need: specialized inpatient rehabilitation for patients recovering from strokes, traumatic brain injuries, spinal cord injuries, hip fractures, and other debilitating neurological and orthopedic conditions. Approximately 92% of Encompass patients are transferred directly from acute care hospitals following physician referrals, making these services fundamentally non-discretionary. The aging U.S. population ensures that demand for inpatient rehabilitation will continue to grow for decades. Encompass was named America’s Most Awarded Leader in Inpatient Rehabilitation by Newsweek and ranked among Fortune’s World’s Most Admired Companies, reflecting both its clinical excellence and market dominance.

Why Encompass Health Matters for NNN Investors

Inpatient rehabilitation hospitals occupy a unique position in healthcare real estate. These are large, purpose-built facilities (typically 30,000 to 80,000 square feet) designed specifically for intensive rehabilitation with specialized equipment, therapy gyms, patient rooms configured for extended stays, and clinical infrastructure that cannot be easily replicated or repurposed. Encompass’s development strategy increasingly involves joint ventures with acute care health systems, which both strengthens the referral pipeline and creates structured NNN investment opportunities where the property is owned by an investor or partner and leased back to Encompass.

The company’s expansion pipeline is robust: Encompass plans to continue adding 400 to 500 beds annually through new hospital construction and capacity additions at existing sites. Each new hospital represents a potential NNN investment opportunity in the $15 to $40 million range. The combination of strong revenue growth (10.5% in 2025), improving margins, and a positive rating outlook from Moody‑s positions Encompass as one of the stronger non-investment-grade healthcare tenants available to NNN investors. If the company achieves an investment grade rating, existing NNN leases would see meaningful cap rate compression, creating potential upside for current holders.

Cap Rate Analysis & Pricing for Encompass Health NNN Properties

Encompass Health NNN properties trade in the 6.50% to 7.75% cap rate range as of Q1 2026. The range is tighter than typical BB-rated tenants because of Encompass’s sector dominance, strong revenue growth trajectory, and Moody‑s positive outlook. Newer hospitals with 15+ year remaining terms, health system joint venture partners, and locations in high-demand markets trade toward the tighter end. Older facilities, secondary markets, or shorter remaining terms trade wider.

Pricing for Encompass NNN properties typically ranges from $8 million for smaller rehabilitation hospitals to $40 million or more for large, newly constructed facilities. The institutional scale of these assets means that healthcare REITs, pension funds, and large private investors are the primary buyer pool. Encompass generated approximately $1 billion in operating cash flows in 2025 and $75 million in free cash flow after investments, providing strong coverage of its lease obligations.